Ignite Creation Date:
2024-05-05 @ 4:36 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00278980
Status:
COMPLETED
Last Update Posted:
2006-01-19
First Post:
2006-01-12
Brief Title:
Effect of C-Peptide on Diabetic Peripheral Neuropathy
Sponsor:
Creative Peptides Sweden Inc
Organization:
Creative Peptides Sweden Inc
Study Overview
Official Title:
Effect of C-Peptide on Diabetic Peripheral Neuropathy a 6 Months Randomized Double-Blind Placebo Controlled Dose-Finding Multicenter Study With Parallel Groups
Status:
COMPLETED
Status Verified Date:
2006-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the study is to investigate the effect of C-peptide administration on nerve function in patients with type 1 diabetes and peripheral sensory neuropathy
Detailed Description:
It has been observed that C-peptide administration results in an activation of renal tubular and sciatic endoneural NaK-ATPase of the rat and stimulation of endothelial nitric oxide synthase The hypothesis is that C-peptide administration may improve peripheral nerve dysfunction in diabetic neuropathy by increasing nerve blood flow and NaK-ATPase activity The purpose of the trial is to investigate the effect of C-peptide administration on diabetic peripheral sensory neuropathy in patients with type 1 diabetes and diabetic neuropathy in the lower extremities
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None